本研究针对白内障合并散光患者，评估了AcrySof IQ Vivity Toric EDOF（扩展景深）人工晶状体（IOL）的临床疗效。研究通过前瞻性观察发现，该IOL在术后3个月可实现良好的中距离矫正视力（DCIVA为0.16 logMAR），且旋转稳定性优异（86%病例旋转≤5°），患者在中、远距离 ...

本研究针对儿童板层白内障患者视力重建难题，探索了非衍射型景深延长（EDOF）人工晶状体（IOL）双侧植入的临床效果。通过标准超声乳化手术植入AcrySof IQ Vivity IOL，术后三月患者远、中距离视力显著提升（UDVA 0.1 logMAR，UIVA 0.1–0.2 logMAR），光学现象轻微，对比 ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today revealed final data from its Vivity ® Registry Study, which monitored ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...

Latest addition to Alcon’s intraocular lens (IOL) portfolio expands surgeons’ presbyopia-correcting IOL (PC-IOL) offerings Vivity X-WAVE technology delivers extended range of vision while maintaining ...

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...

Please provide your email address to receive an email when new articles are posted on . MILAN — In difficult eyes or eyes with comorbidities in which diffractive trifocal IOLs are not an option, the ...